CenterBook Partners LP Increases Stock Position in Addus HomeCare Corporation $ADUS

CenterBook Partners LP lifted its holdings in Addus HomeCare Corporation (NASDAQ:ADUS) by 149.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,799 shares of the company’s stock after buying an additional 5,874 shares during the quarter. CenterBook Partners LP owned approximately 0.05% of Addus HomeCare worth $1,052,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Capital Research Global Investors boosted its stake in Addus HomeCare by 22.3% during the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after acquiring an additional 268,192 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Addus HomeCare by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after purchasing an additional 10,501 shares in the last quarter. Wasatch Advisors LP increased its stake in shares of Addus HomeCare by 0.8% during the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after purchasing an additional 7,089 shares in the last quarter. State Street Corp lifted its holdings in shares of Addus HomeCare by 1.3% during the second quarter. State Street Corp now owns 693,368 shares of the company’s stock valued at $79,869,000 after purchasing an additional 8,925 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Addus HomeCare by 1.2% during the third quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company’s stock valued at $78,729,000 after purchasing an additional 7,884 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

ADUS stock opened at $93.17 on Thursday. The stock’s 50 day simple moving average is $93.75 and its 200 day simple moving average is $103.52. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The stock has a market capitalization of $1.74 billion, a PE ratio of 17.22, a price-to-earnings-growth ratio of 1.27 and a beta of 0.89.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The business had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. During the same quarter last year, the company earned $1.42 EPS. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. As a group, research analysts forecast that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ADUS has been the topic of several recent research reports. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Weiss Ratings cut Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Stephens dropped their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Royal Bank Of Canada reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Wednesday, February 25th. Finally, Barclays reduced their price target on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $131.00.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.